Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194194 · ClinicalTrials.gov registry record · Phase 2
Healthetech, Inc. SMART Study
A Phase 2 study of Moderate Behavior Management and Intensive Behavior Management, sponsored by Temple University.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00194194: Completed Phase 2 study of Moderate Behavior Management and Intensive Behavior Management, sponsored by Temple University.
NCT00194194 is a Phase 2 study of Moderate Behavior Management and Intensive Behavior Management that has completed, run by Temple University. The registered enrollment target is 56 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194194, a Phase 2 study of Moderate Behavior Management and Intensive Behavior Management, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to gain experience with the HealtheTech measurement system (BalanceLog) in the context of a clinical trial and to develop the related treatment protocols. In this study the aim is to evaluate two interventions, one moderate and the other intensive behavioral management. The development and evaluation of a HealtheTech protocol across these two treatment settings will provide useful data about implementation (e.g., technical issues, clinical issues, participant satisfaction) and outcomes (weight loss, retention). These data can provide empirical and clinical support for practice guidelines.
Conditions Studied
Interventions
- BEHAVIORAL moderate
- DEVICE Resting Metablic Rate measurements
Study Locations (1)
Pennsylvania
- Temple University- Center for Obesity Research and Education - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00194194 record still lists
NCT00194194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Moderate Behavior Management appearing as the primary indexed condition, and to 2 interventions - of which moderate is the first listed.
NCT00194194 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00194194 about?
NCT00194194 is a clinical study titled "Healthetech, Inc. SMART Study". This study is designed to gain experience with the HealtheTech measurement system (BalanceLog) in the context of a clinical trial and to develop the related treatment protocols. In this study the aim is to evaluate two interventions, one moderate and the other intensive behavioral management. The de...
What is the current status of trial NCT00194194?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2004-08. Estimated completion is 2007-03.
What conditions does trial NCT00194194 study?
This clinical trial studies the following conditions: Moderate Behavior Management, Intensive Behavior Management.
What interventions are being tested in trial NCT00194194?
The interventions under investigation include: moderate (BEHAVIORAL), Resting Metablic Rate measurements (DEVICE).
Who is sponsoring clinical trial NCT00194194?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194194 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00194194's enrollment target sits among peer trials
56 1146th of 2000 higher than 848 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia